nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0217	0.0217	CbGpPWpGaD
Perphenazine—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0217	0.0217	CbGpPWpGaD
Perphenazine—HTR1A—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0202	0.0202	CbGpPWpGaD
Perphenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0187	0.0187	CbGpPWpGaD
Perphenazine—DRD2—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0178	0.0178	CbGpPWpGaD
Perphenazine—HTR6—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0166	0.0166	CbGpPWpGaD
Perphenazine—HTR7—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0165	0.0165	CbGpPWpGaD
Perphenazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0161	0.0161	CbGpPWpGaD
Perphenazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.016	0.016	CbGpPWpGaD
Perphenazine—ADRA2A—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0159	0.0159	CbGpPWpGaD
Perphenazine—DRD1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0142	0.0142	CbGpPWpGaD
Perphenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0141	0.0141	CbGpPWpGaD
Perphenazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0139	0.0139	CbGpPWpGaD
Perphenazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0139	0.0139	CbGpPWpGaD
Perphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0126	0.0126	CbGpPWpGaD
Perphenazine—CALM3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0123	0.0123	CbGpPWpGaD
Perphenazine—HTR1A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0123	0.0123	CbGpPWpGaD
Perphenazine—HTR2C—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Perphenazine—CALM2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0119	0.0119	CbGpPWpGaD
Perphenazine—CALM1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0119	0.0119	CbGpPWpGaD
Perphenazine—CALM3—Downstream signal transduction—FRS2—nasal cavity cancer	0.0116	0.0116	CbGpPWpGaD
Perphenazine—CALM3—Signaling by FGFR—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Perphenazine—CALM3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Perphenazine—CALM3—DAP12 signaling—FRS2—nasal cavity cancer	0.0114	0.0114	CbGpPWpGaD
Perphenazine—CALM2—Downstream signal transduction—FRS2—nasal cavity cancer	0.0112	0.0112	CbGpPWpGaD
Perphenazine—CALM1—Downstream signal transduction—FRS2—nasal cavity cancer	0.0112	0.0112	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR—FRS2—nasal cavity cancer	0.0111	0.0111	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR—FRS2—nasal cavity cancer	0.0111	0.0111	CbGpPWpGaD
Perphenazine—CALM2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0111	0.0111	CbGpPWpGaD
Perphenazine—CALM1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0111	0.0111	CbGpPWpGaD
Perphenazine—CALM2—DAP12 signaling—FRS2—nasal cavity cancer	0.011	0.011	CbGpPWpGaD
Perphenazine—CALM1—DAP12 signaling—FRS2—nasal cavity cancer	0.011	0.011	CbGpPWpGaD
Perphenazine—DRD2—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0108	0.0108	CbGpPWpGaD
Perphenazine—CALM3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Perphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Perphenazine—CALM3—DAP12 interactions—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR—FRS2—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Perphenazine—HTR2A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Perphenazine—HRH1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0105	0.0105	CbGpPWpGaD
Perphenazine—CALM3—Signaling by PDGF—FRS2—nasal cavity cancer	0.0105	0.0105	CbGpPWpGaD
Perphenazine—CALM2—DAP12 interactions—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Perphenazine—CALM1—DAP12 interactions—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Perphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Perphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Perphenazine—CALM2—Signaling by PDGF—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Perphenazine—CALM1—Signaling by PDGF—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Perphenazine—CALM3—B Cell Activation—FRS2—nasal cavity cancer	0.00993	0.00993	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00963	0.00963	CbGpPWpGaD
Perphenazine—CALM1—B Cell Activation—FRS2—nasal cavity cancer	0.00961	0.00961	CbGpPWpGaD
Perphenazine—CALM2—B Cell Activation—FRS2—nasal cavity cancer	0.00961	0.00961	CbGpPWpGaD
Perphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0095	0.0095	CbGpPWpGaD
Perphenazine—HTR6—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00935	0.00935	CbGpPWpGaD
Perphenazine—HTR7—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00934	0.00934	CbGpPWpGaD
Perphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00919	0.00919	CbGpPWpGaD
Perphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00919	0.00919	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00849	0.00849	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00848	0.00848	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00805	0.00805	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00731	0.00731	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—FRS2—nasal cavity cancer	0.00731	0.00731	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—FRS2—nasal cavity cancer	0.00707	0.00707	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—FRS2—nasal cavity cancer	0.00707	0.00707	CbGpPWpGaD
Perphenazine—AOX1—Disease—FRS2—nasal cavity cancer	0.00694	0.00694	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00692	0.00692	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00689	0.00689	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00629	0.00629	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00625	0.00625	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00608	0.00608	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00598	0.00598	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00597	0.00597	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00552	0.00552	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00544	0.00544	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00543	0.00543	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00542	0.00542	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CXCL11—nasal cavity cancer	0.00502	0.00502	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CXCL11—nasal cavity cancer	0.00501	0.00501	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00494	0.00494	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00451	0.00451	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00436	0.00436	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00436	0.00436	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00432	0.00432	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—FRS2—nasal cavity cancer	0.00417	0.00417	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—FRS2—nasal cavity cancer	0.00403	0.00403	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—FRS2—nasal cavity cancer	0.00403	0.00403	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—FRS2—nasal cavity cancer	0.004	0.004	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00387	0.00387	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00387	0.00387	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00371	0.00371	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CXCL11—nasal cavity cancer	0.0037	0.0037	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00326	0.00326	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00321	0.00321	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL11—nasal cavity cancer	0.0032	0.0032	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—FRS2—nasal cavity cancer	0.00296	0.00296	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—FRS2—nasal cavity cancer	0.00295	0.00295	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00292	0.00292	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00266	0.00266	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00258	0.00258	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00258	0.00258	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—FRS2—nasal cavity cancer	0.00255	0.00255	CbGpPWpGaD
Perphenazine—CALM3—Immune System—FRS2—nasal cavity cancer	0.00243	0.00243	CbGpPWpGaD
Perphenazine—CALM2—Immune System—FRS2—nasal cavity cancer	0.00235	0.00235	CbGpPWpGaD
Perphenazine—CALM1—Immune System—FRS2—nasal cavity cancer	0.00235	0.00235	CbGpPWpGaD
Perphenazine—CALM3—Disease—FRS2—nasal cavity cancer	0.00224	0.00224	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00219	0.00219	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—FRS2—nasal cavity cancer	0.00218	0.00218	CbGpPWpGaD
Perphenazine—CALM2—Disease—FRS2—nasal cavity cancer	0.00217	0.00217	CbGpPWpGaD
Perphenazine—CALM1—Disease—FRS2—nasal cavity cancer	0.00217	0.00217	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—FRS2—nasal cavity cancer	0.00192	0.00192	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—FRS2—nasal cavity cancer	0.00189	0.00189	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—FRS2—nasal cavity cancer	0.00189	0.00189	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—FRS2—nasal cavity cancer	0.00172	0.00172	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—FRS2—nasal cavity cancer	0.00157	0.00157	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00152	0.00152	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00152	0.00152	CbGpPWpGaD
